Rho SVP R&D Serving on Panel, Presenting during DIA 50th Annual Meeting in San Diego

CHAPEL HILL, NC, UNITED STATES - Jun 10, 2014 - Rho SVP R&D Serving on Panel, Presenting during

DIA 50th Annual Meeting in San Diego

WHAT:           Rho, a full-service contract research organization (CRO), is showcasing its                             30-year history of success in drug development strategies and services at                       the 2014 Drug Information Association (DIA) 50th Annual “Celebrate the Past -                       Invent the Future,” Meeting, June 15-19 in San Diego.  Attendees are invited to                       stop by Rho’s booth (#427) to meet some of their leading drug development                           experts and learn more about the company’s rich 30-year history in the                                 industry.

                        David Shoemaker, Ph.D., Senior Vice President, Research and Development                         for Rho, will serve as a panelist for a discussion regarding "The Changing                               Landscape for Bioinnovation:  The Emergence of Small Pharma, Strategic                             Alliances, and Precision  Medicine" on Tuesday,June 17 at 8 a.m.

                        Dr. Shoemaker will also be giving a presentation "Key Tips for Orphan                                   Product Development" during the session "Optimizing Orphan Drug                                       Development and Using Appropriate Methodology: Key Tips for Success" on                           Wednesday, June 18 at 1:30 PM.

                        More than 7,000 people will gather at the 50th Annual Meeting for an                                     invaluable forum for professionals involved in the discovery, development, and                         life-cycle management of pharmaceuticals, medical devices, and related                                 products, including discussion of current and evolving areas such as                                     comparative effectiveness research, health outcomes, and drug/device                                   combination products.

WHO:    Rho Attendees:

• David Shoemaker, Ph.D., Senior Vice President, Research and Development
• David Cass, Senior Director Business Development
• KC Morris, Director Business Development
• Kelly Giles, Business Development Associate
• Chris Walker, Business Development Associate
• Jamie Hahn, Senior Director, Corporate Communications

                        Interview Opportunities:  David Shoemaker and Jamie Hahn

WHEN:           June 15-19

WHERE:        San Diego Convention Center

                    111 W Harbor Dr, San Diego, CA 92101

                    Booth No. 427

DETAILS:      For media inquiries, please contact Jessica Highsmith at Largemouth Communications, (919) 459-6456, jessica@largemouthpr.com or Jamie Hahn, Senior Director Corporate Communications for Rho, jamie_hahn@rhoworld.com.

ABOUT:         Rho, a privately-held, contract research organization (CRO) located in Chapel                      Hill, NC, provides a full range of clinical research services across the entire drug                      development process. For 30 years, Rho has been a trusted partner to                      some of the industry’s leading pharmaceutical, biotechnology, and medical                            device companies as well as academic and government organizations. Our                            commitment to excellence, our innovative technologies, and our therapeutic                            expertise accelerate time to market, maximize returns on investment, and lead                      to an exceptional customer experience. For more information, please visit                      www.rhoworld.com and follow us on Twitter.

                                                                     ###